Skip to main content
Kent Sepkowitz, MD, Infectious Disease, New York, NY

KentASepkowitzMD

Infectious Disease New York, NY

Professor, Medicine, Weill Cornell Medical College

Dr. Sepkowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sepkowitz's full profile

Already have an account?

  • Office

    1275 York Avenue
    New York, NY 10065

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 1988 - 1991
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1980 - 1984
  • University of Oklahoma College of Medicine
    University of Oklahoma College of MedicineClass of 1980

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1986 - Present
  • NY State Medical License
    NY State Medical License 1981 - 2026
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 1996

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Opinion: These Tests to Determine Who's Immune Could Help Us Face Future Covid Surges
    Opinion: These Tests to Determine Who's Immune Could Help Us Face Future Covid SurgesJune 29th, 2022
  • The Case for Covid Boosters Just Got Stronger
    The Case for Covid Boosters Just Got StrongerNovember 2nd, 2021
  • Merck's Covid-19 Pill Is Great News but May Not Be a Game-Changer
    Merck's Covid-19 Pill Is Great News but May Not Be a Game-ChangerOctober 2nd, 2021
  • Join now to see all

Grant Support

  • Clinical Research And Mentoring In Infectious DiseaseNational Institute Of Allergy And Infectious Diseases2002–2006
  • Prevention Epicenters ProgramNational Center For Infectious Diseases (Ncid)1998–2005
  • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1999–2001
  • Tolerance, Safety And Activity Of Rifapentine Alone And In Combination/ AIDSNational Center For Research Resources1997–1999

Professional Memberships